Camlin Fine Sciences Ltd — Regulatory Filings 2021

Jun 2, 2021

==> picture [100 x 31] intentionally omitted <==

June 2, 2021

||To,BSE Limited,25, P. J. Towers,Dalal Street,Mumbai – 400 001**Ref:**Company Scrip Code: 532834|To,The Manager,Listing Department,National Stock Exchange of India Ltd.,Exchange Plaza, Bandra Kurla Complex,Bandra (East), Mumbai‐ 400051**Ref:Symbol:**CAMLINFINE || Series: EQ| |---|---|---|

Sub: Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ‐ (“SEBI LODR”)

This is to inform you that on Thursday the June 3, 2021, the senior management team of the Company shall engage in a conference call organized by Nirmal Bang Institutional Equities with various domestic and international investors and analysts to discuss the financial results for the quarter and financial year ended March 31, 2021 (Q4).

We request you to take the above on record and the same be treated as compliance under the applicable Regulations of SEBI LODR.

Note: The date of the scheduled call is subject to change due to exigencies on the part of Investors/Company.

Thanking You, Encl.: a/a. For Camlin Fine Sciences Limited Mandar Godbole Company Secretary & Compliance Officer

==> picture [426 x 57] intentionally omitted <==